Kendall Park, NJ, United States of America

Thiruvettipuram K Thiruvengadam

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thiruvettipuram K Thiruvengadam. Retrieved from https://idiyas.com/inventor/thiruvettipuram-k-thiruvengadam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thiruvettipuram K Thiruvengadam: Innovator in Phosphonate Chemistry

Introduction

Thiruvettipuram K Thiruvengadam is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of phosphonate esters. His work is essential for the development of pharmaceutical compounds.

Latest Patents

Thiruvengadam holds a patent for the "Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate." This application discloses a novel process for preparing phosphonate esters that serve as intermediates in the synthesis of himbacine analogs. These analogs are valuable as thrombin receptor antagonists. The chemistry involved includes various alkyl, aryl, and heteroaryl groups, along with the use of palladium catalysts.

Career Highlights

Thiruvengadam is associated with Merck Sharp & Dohme Corp., where he applies his expertise in chemical synthesis. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

He has collaborated with notable coworkers, including Kelvin Yong and Ilia A Zavialov, enhancing the innovative efforts within his team.

Conclusion

Thiruvettipuram K Thiruvengadam is a distinguished inventor whose work in phosphonate chemistry has significant implications for drug development. His contributions continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…